Physician profile
James Cross
NPI 1013950625
$5,929.31
in general payments reported to CMS, 2019-2025
15 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,389 · 2021: $292 · 2022: $575 · 2023: $1,209 · 2024: $845 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,145 · Honoraria: $500 · Entertainment: $27.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,145.45 |
| Honoraria | $500.00 |
| Entertainment | $27.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $1,192.31 | 2022-2025 | Epicel (Cultured Epidermal Autografts), Nexobrid |
| Access Pro Medical, LLC | $957.90 | 2022-2025 | Matriderm |
| Kci USA, INC. | $926.31 | 2019 | |
| Polynovo North America LLC | $718.66 | 2019-2024 | Novosorb Btm |
| Avita Medical Americas, LLC | $636.25 | 2019-2025 | Recell, Permeaderm, Cohealyx |
| Kerecis Limited | $543.38 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $501.94 | 2021-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Acelrx Pharmaceuticals, INC. | $118.74 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $108.99 | 2019 | |
| Medline Industries LP | $107.64 | 2023 | |
| Teleflex LLC | $31.52 | 2024 | Quikclot |
| Argentum Medical | $27.67 | 2025 | |
| Lifenet Health | $23.48 | 2024 | Theragenesis Wound Matrix |
| Mallinckrodt Hospital Products INC. | $17.40 | 2021 | |
| Baxter Healthcare | $17.12 | 2023 | Artiss |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.